Investor
LSX USA Congress
A partnering and investment event connecting life science executives with venture capital firms to negotiate funding and licensing agreements.
- When
- September, Mid September
- Where
- Boston, United States
- Format
- In person
- Organiser
- LSX
- Region
- North America
- Scale
- About 600 attendees
- Founded
- 2013
The briefing
The LSX USA Congress, held in the biotech hub of Boston, focuses on executive-level networking and deal-making in the life sciences. The event connects biotech, medtech, and healthtech executives with active healthcare investors and pharmaceutical business development leads. Through a structured partnering system, attendees pitch clinical pipelines and digital platforms for venture rounds or acquisitions. For early-to-late stage companies, it is a key venue to build relationships with global capital partners.
What to expect
- One-on-one investment pitch and partnership matching sessions
- Panels on the macroeconomic environment for life science public offerings
- Discussions on pharma-biotech asset licensing and transaction models
Who is in the room
Life science chief executive officers, pharma business development executives, venture capitalists, and private equity investors.
Background
Originated in the United Kingdom as a high-level networking club for life science executives before expanding its conference model globally. The USA Congress was launched to bridge European and American investment ecosystems in the Boston biotech corridor.
Related events
Running this event, or spotted something out of date?